Skip To Main Content
FMH College on Muck Rack

FMH College

As seen in: Wiley Online Library, The International Journal for Quality in Health Care, Annals of the Rheumatic Diseases, BMC Genomics, The Journal of Hospital Infection, Pakistan Armed Forces Medical Journal, The Professional Medical Journal, The Journal of Musculoskeletal Surgery and Research (JMSR)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with FMH

Contact FMH, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Integration of artificial intelligence in the MBBS curriculum

|
By Muhammad Waqas, FMH College, Sharjeel Haider
| jpma.org.pk
Abstract Dear editor, The growing influence of artificial intelligence (AI) is rapidly and profoundly changing our healthcare system.
Open in Who Shared Issue with article?

Efficacy and safety of Depemokimab in asthma with eosinophilic phenotype: a systematic review and meta-analysis of randomized controlled trials - BMC Immunology

|
By Muhammad Nabeel, FMH College, Basir Afzaal
| link.springer.com
Abstract Asthma is a complex and heterogeneous disease that significantly impacts quality of life. Eosinophilic asthma, characterized by elevated eosinophil levels, leads to inflammation and hypersensitivity. Many patients remain inadequately managed, resulting in frequent exacerbations and hospitalizations despite standard treatment options. Depemokimab, a long-acting monoclonal antibody that targets IL-5, could offer a novel approach for managing severe eosinophilic asthma.
Open in Who Shared Issue with article?

The APLAR Recommendations for the Management of Psoriatic Arthritis

|
By Ying-Ying Leung, Paul Bird, Muhammad Haroon, FMH College
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. A.J.M. has received research grants from Novartis and speaker fees from CIPLA laboratories, Janssen, and Abbott. L.S.T. received speaker or consultant fee from AbbVie, Boehringer Ingelheim, Eli Lilly, Janssen, Pfizer, and Sanofi; grant/research support from Amgen, Boehringer Ingelheim, Janssen, GlaxoSmithKline, Novartis, and Pfizer.
Open in Who Shared Issue with article?
See all 18 articles